Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatment

Strides Pharma Science Ltd on Wednesday said it has developed and
commercialised Favipiravir antiviral tablets and stressed that the
drug has demonstrated positive outcomes in COVID-19 treatment
globally.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-develops-favipiravir-antiviral-tablets-drug-shows-positive-outcome-in-covid-19-treatment/articleshow/75445430.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 30.11.2021 CSIR-IGIB Rs 1.5 Lakh pm Pay Job, ACTREC High Pay

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission